Xvivo Perfusion AB's market cap is currently ―. The company's EPS TTM is $0.615; its P/E ratio is ―; Xvivo Perfusion AB is scheduled to report earnings on January 28, 2025, and the estimated EPS forecast is $0.13. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	$ 140.62M	$ 131.51M	$ 96.83M	$ 94.29M	$ 92.65M
Gross Profit	$ 104.82M	$ 94.86M	$ 69.37M	$ 67.51M	$ 65.22M
EBIT	$ 11.21M	$ 18.81M	$ -4.66M	$ 4.14M	$ 4.62M
EBITDA	$ 11.21M	$ 18.81M	$ -4.66M	$ 4.14M	$ 4.62M
Net Income Common Stockholders	$ 14.18M	$ 734.00K	$ 5.40M	$ 7.53M	$ 4.76M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 197.95M	$ 246.54M	$ 314.56M	$ 317.88M	$ 339.78M
Total Assets	$ 1.74B	$ 1.73B	$ 1.64B	$ 1.58B	$ 1.52B
Total Debt	$ 292.99M	$ 10.01M	$ 5.54M	$ 6.42M	$ 5.14M
Net Debt	$ 95.03M	$ -236.54M	$ -309.02M	$ -311.46M	$ -334.64M
Total Liabilities	$ 292.99M	$ 302.95M	$ 259.87M	$ 239.00M	$ 224.98M
Stockholders Equity	$ 1.45B	$ 1.43B	$ 1.38B	$ 1.35B	$ 1.30B
Cash Flow	-
Free Cash Flow	$ -12.43M	$ -109.16M	$ 16.97M	$ -1.56M	$ -9.35M
Operating Cash Flow	$ -12.43M	$ 21.79M	$ 16.97M	$ -1.56M	$ -9.35M
Investing Cash Flow	$ -33.53M	$ -77.05M	$ -33.72M	$ -34.48M	$ -52.37M
Financing Cash Flow	$ -2.49M	$ -2.80M	$ -1.62M	$ -556.00K	$ -1.86M

Currency in USD

Xvivo Perfusion AB Earnings and Revenue History

Income Statement >

Xvivo Perfusion AB Debt to Assets

Balance Sheet >

Xvivo Perfusion AB Cash Flow

Cash Flow >

Xvivo Perfusion AB Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing